Cargando…

Association of Thrombosis With Hypereosinophilic Syndrome in Patients With Genetic Alterations

IMPORTANCE: Hypereosinophilic syndromes (HESs) are a rare group of disorders that result in overproduction of eosinophils, leading to tissue damage. Thrombotic complications in HES and associated risk factors in this patient population have not been extensively studied. OBJECTIVE: To investigate the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leiva, Orly, Baker, Olesya, Jenkins, Andrew, Brunner, Andrew M., Al-Samkari, Hanny, Leaf, Rebecca Karp, Rosovsky, Rachel P., Fathi, Amir T., Weitzman, James, Bornikova, Larissa, Nardi, Valentina, Hobbs, Gabriela S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346937/ https://www.ncbi.nlm.nih.gov/pubmed/34357393 http://dx.doi.org/10.1001/jamanetworkopen.2021.19812

Ejemplares similares

Patients with myeloproliferative neoplasms and COVID‐19 have increased rates of arterial thrombosis
por: Leiva, Orly, et al.
Publicado: (2022)

Increased Risk of Thrombosis in Patients with Myeloproliferative Neoplasms Compared with the General Population Hospitalized with COVID-19
por: Leiva, Orly, et al.
Publicado: (2021)

Risk Factors for Death or Cardiovascular Events after Acute Coronary Syndrome in Patients with Myeloproliferative Neoplasms
por: Leiva, Orly, et al.
Publicado: (2023)

COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection
por: Al-Samkari, Hanny, et al.
Publicado: (2020)

Impact of Tumor Genomic Mutations on Thrombotic Risk in Cancer Patients
por: Leiva, Orly, et al.
Publicado: (2020)

Direct oral anticoagulants for treatment and prevention of venous thromboembolism in cancer patients
por: Song, Andrew B, et al.
Publicado: (2019)

The Role of Direct Oral Anticoagulants in Treatment of Cancer-Associated Thrombosis
por: Al-Samkari, Hanny, et al.
Publicado: (2018)

Evaluation of the Prothrombin Fragment 1.2 in Patients with COVID-19
por: Al-Samkari, Hanny, et al.
Publicado: (2020)

Hypereosinophilic syndrome presenting as coagulopathy
por: Aukstuolis, Kestutis, et al.
Publicado: (2022)

A Rare Case of Aortic Valve Thrombosis in Patient with Idiopathic Hypereosinophilic Syndrome
por: Grolla, Elisabetta, et al.
Publicado: (2015)

Acute pulmonary embolism and deep vein thrombosis secondary to idiopathic hypereosinophilic syndrome
por: Li, Dezhi, et al.
Publicado: (2018)

Thrombosis in the portal venous system caused by hypereosinophilic syndrome: A case report
por: Lin, Jinfeng, et al.
Publicado: (2018)

Hypereosinophilic syndromes
por: Roufosse, Florence E, et al.
Publicado: (2007)

Genomics of PDGFR-rearranged hypereosinophilic syndrome
por: Rheinbay, Esther, et al.
Publicado: (2023)

Imaging Diagnosis for Left Ventricular Thrombosis in Idiopathic Hypereosinophilic Syndrome: Two Case Reports
por: He, Yu-Quan, et al.
Publicado: (2014)

Giant Coronary Artery Aneurysm with Thrombosis Complicated in a Patient with Idiopathic Hypereosinophilic Syndrome
por: Kang, Noeul, et al.
Publicado: (2023)

COVID-19 vaccination and immune thrombocytopenia: Cause for vigilance, but not panic
por: Al-Samkari, Hanny
Publicado: (2023)

Pulmonary Hypertension in Myeloproliferative Neoplasms: New Insights and Unexplored Horizons
por: Leiva, Orly, et al.
Publicado: (2023)

A multicenter study of romiplostim for chemotherapy-induced thrombocytopenia in solid tumor s and hematologic malignancies
por: Al-Samkari, Hanny, et al.
Publicado: (2020)

Cardiac involvement in hypereosinophilic syndrome
por: Mansour, Mohamad Jihad, et al.
Publicado: (2018)

Eosinophilic myocarditis and hypereosinophilic syndrome
por: Boussir, Hanane, et al.
Publicado: (2017)

Hypereosinophilic Syndrome With Eosinophilic Gastritis
por: Nayak, Vignesh Hebri, et al.
Publicado: (2017)

Cardiovascular Disease in Myeloproliferative Neoplasms: JACC: CardioOncology State-of-the-Art Review
por: Leiva, Orly, et al.
Publicado: (2022)

P1029: JAK2-CHIP IS ASSOCIATED WITH SIMILAR RISK OF CARDIOVASCULAR DISEASE AS JAK2-MPN
por: Grevet, Jeremy, et al.
Publicado: (2023)

Hypereosinophilic syndrome presenting with multiple organ infiltration and deep venous thrombosis: A case report and literature review
por: Gao, Su-jun, et al.
Publicado: (2016)

Helicobacter pylori infection manifesting as Hypereosinophilic syndrome and immune thrombocytopenia complicated by portal vein thrombosis and ischemic colitis
por: Alshurafa, Awni, et al.
Publicado: (2022)

Management of Adult Patients with Immune Thrombocytopenia (ITP): A Review on Current Guidance and Experience from Clinical Practice
por: Song, Fei, et al.
Publicado: (2021)

Gastrointestinal and Hepatic Involvement in Hypereosinophilic Syndrome
por: Inayat, Faisal, et al.
Publicado: (2016)

Clinical and Biological Markers in Hypereosinophilic Syndromes
por: Khoury, Paneez, et al.
Publicado: (2017)

Idiopathic hypereosinophilic syndrome with pulmonary hypertension
por: Zhang, Liping, et al.
Publicado: (2018)

Hypereosinophilic vasculitis: A case report
por: Alzayer, Husam, et al.
Publicado: (2019)

COVID-19 Pneumonia or Hypereosinophilic Syndrome?
por: Serin, Istemi, et al.
Publicado: (2020)

Literature reviews of stroke with hypereosinophilic syndrome
por: Ono, Ryohei, et al.
Publicado: (2021)

Crusted Scabies Induced Hypereosinophilic Syndrome
por: Shrestha, Asis, et al.
Publicado: (2021)

Hypereosinophilic Dermatitis: Successful Treatment with Dupilumab
por: Wu, Chenyu, et al.
Publicado: (2023)

The dermatologic and histologic spectrum of hypereosinophilic syndrome
por: Long, Calista, et al.
Publicado: (2023)

Idiopathic hypereosinophilic syndrome presenting with liver mass: Report of two cases: Idiopathic hypereosinophilic syndrome and liver mass
por: shatery, Kamran, et al.
Publicado: (2011)

Outcomes of Patients With Myeloproliferative Neoplasms Admitted With Myocardial Infarction: Insights From National Inpatient Sample
por: Leiva, Orly, et al.
Publicado: (2023)

Optimal use of thrombopoietin receptor agonists in immune thrombocytopenia
por: Al-Samkari, Hanny, et al.
Publicado: (2019)

Avatrombopag for the treatment of immune thrombocytopenia and thrombocytopenia of chronic liver disease
por: Cheloff, Abraham Z, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kgba1d3p14v6ps4uvuvioimbau